The Future of IBS

The Future of IBS

The Future of IBS

Overview

71% of patients were able to better manage their IBS in the first randomised controlled trial (RCT) for Nerva, a hypnotherapy app for IBS. But practitioners were still reaching for low-FODMAP.

So we brought the evidence in front of them. An expert panel turned Nerva's clinical evidence into a conversation practitioners could join.

The campaign stayed close to Nerva's existing identity on purpose. A practitioner might see Nerva at the event, then encounter it again on a referral form months later. The job wasn't to create a new campaign world. It was to make Nerva more memorable within the world it already owned. The only new element was an arrow through the lockup, a visual cue for hypnotherapy moving towards first-line treatment.

Over 1,000 registered, 25% attended, and referrals to Nerva’s hypnotherapy app grew alongside it.

71% of patients were able to better manage their IBS in the first randomised controlled trial (RCT) for Nerva, a hypnotherapy app for IBS. But practitioners were still reaching for low-FODMAP.


So we brought the evidence in front of them. An expert panel turned Nerva's clinical evidence into a conversation practitioners could join.


The campaign stayed close to Nerva's existing identity on purpose. A practitioner might see Nerva at the event, then encounter it again on a referral form months later. The job wasn't to create a new campaign world. It was to make Nerva more memorable within the world it already owned. The only new element was an arrow through the lockup, a visual cue for hypnotherapy moving towards first-line treatment.


Over 1,000 registered, 25% attended, and referrals to Nerva’s hypnotherapy app grew alongside it.

71% of patients were able to better manage their IBS in the first randomised controlled trial (RCT) for Nerva, a hypnotherapy app for IBS. But practitioners were still reaching for low-FODMAP.


So we brought the evidence in front of them. An expert panel turned Nerva's clinical evidence into a conversation practitioners could join.


The campaign stayed close to Nerva's existing identity on purpose. A practitioner might see Nerva at the event, then encounter it again on a referral form months later. The job wasn't to create a new campaign world. It was to make Nerva more memorable within the world it already owned. The only new element was an arrow through the lockup, a visual cue for hypnotherapy moving towards first-line treatment.


Over 1,000 registered, 25% attended, and referrals to Nerva’s hypnotherapy app grew alongside it.

Client

Client

Client

Nerva

Type

Type

Type

B2B

/

Healthcare campaign

Phoebe Owl
Phoebe Owl
Phoebe Owl